Table of Contents (Version-2026)
Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Cancer Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Market Dynamics
Global Cancer Diagnostics Market, By Test Type, 2021 – 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- Tumor Biomarkers Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Segment Trends
- PSA Tests
- CTC Tests
- AFP Tests
- CA-19 Tests
- HER2 Tests
- BRCA Tests
- ALK Tests
- CEA Tests
- EGFR Mutation Tests
- KRAS Mutation Tests
- Others
- Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Segment Trends
- Ultrasound
- Mammography
- MRI Scan
- PET Scan
- CT Scan
- Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Segment Trends
- Needle Biopsy
- Endoscopic Biopsy
- Bone Marrow Biopsy
- Others
- Liquid Biopsy
- Immunohistochemistry
- In Situ Hybridization
- Introduction
Global Cancer Diagnostics Market, By Cancer Type 2021 – 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Blood Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Stomach Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Introduction
Global Cancer Diagnostics Market, By End User 2021 – 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- Hospital Associated Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Independent Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Cancer Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
- Introduction
Global Cancer Diagnostics Market, By Regions, 2021 – 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022–2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Cancer Type, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 – 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- Introduction
Competitive Landscape
- Company Profiles
- Myriad Genetics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Invitae Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- NeoGenomics Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- BPS Bioscience
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Antibodies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Networks LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Euro Diagnostica AB
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- F.Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Qiagen NV
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Augurex Life Sciences Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bio Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Exagen Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Genway Biotech, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Microdrop LLC (imaware)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Svar Life Science AB
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bio Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Koninklijke Philips N.V.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Toshiba Medical Systems Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Aurora Imaging Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Quest Diagnostics.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Myriad Genetics, Inc.
- Company Profiles
Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 34 market data tables and 26 figures on “Global Cancer Diagnostics Market – Global forecast to 2033
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients


